King-Friend Biochemical Pharmaceutical Co. Ltd.
King-Friend Biochemical Pharmaceutical Co. Ltd., commonly referred to as King-Friend, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1995, the company has made significant strides in the development and production of high-quality biochemical products, primarily focusing on APIs (Active Pharmaceutical Ingredients) and intermediates. With a strong operational presence across various regions, King-Friend has built a reputation for its innovative solutions in the pharmaceutical sector. The company’s core offerings include a diverse range of pharmaceutical raw materials, which are distinguished by their purity and compliance with international standards. Recognised for its commitment to quality and sustainability, King-Friend has achieved notable milestones, positioning itself as a trusted partner in the global pharmaceutical supply chain. Its dedication to research and development continues to drive its success in an increasingly competitive market.
DitchCarbon Score
How does King-Friend Biochemical Pharmaceutical Co. Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
King-Friend Biochemical Pharmaceutical Co. Ltd.'s score of 22 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
King-Friend Biochemical Pharmaceutical Co. Ltd.'s reported carbon emissions
As of the latest available data, Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. has not disclosed specific carbon emissions figures for the most recent year. However, the company is committed to addressing climate change through various initiatives. King-Friend Biochemical has made a commitment to near-term reduction targets, although specific numerical targets have not been provided. The company has not yet committed to a net-zero target or defined a long-term reduction strategy. Operating in the Pharmaceuticals, Biotechnology, and Life Sciences sector, King-Friend is part of an industry that is increasingly focused on sustainability and reducing carbon footprints. Their commitment to near-term targets indicates a proactive approach to climate action, aligning with global efforts to mitigate climate change impacts. Overall, while specific emissions data is currently unavailable, King-Friend Biochemical's commitment to near-term climate targets reflects a growing recognition of the importance of sustainability within the pharmaceutical industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
King-Friend Biochemical Pharmaceutical Co. Ltd. is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
